Table S2 from A Phase I Study of ASTX660, an Antagonist of Inhibitors of Apoptosis Proteins, in Adults with Advanced Cancers or Lymphoma

Monica M. Mita,Patricia M. LoRusso,Kyriakos P. Papadopoulos,Michael S. Gordon,Alain C. Mita,Roberta Ferraldeschi,Harold Keer,Aram Oganesian,Xiang Yao Su,Simone Jueliger,Anthony W. Tolcher

crossref（2023）

引用 0|浏览16

暂无评分

摘要

Table S2 shows adverse events (regardless of relationship to study drug) by preferred term in {greater than or equal to}10% of patients in total phase 1 population

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要